CN110787211A - Ginseng eye lotion and preparation method thereof - Google Patents
Ginseng eye lotion and preparation method thereof Download PDFInfo
- Publication number
- CN110787211A CN110787211A CN201911041542.2A CN201911041542A CN110787211A CN 110787211 A CN110787211 A CN 110787211A CN 201911041542 A CN201911041542 A CN 201911041542A CN 110787211 A CN110787211 A CN 110787211A
- Authority
- CN
- China
- Prior art keywords
- parts
- ginsenoside
- vitamin
- ginseng
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a ginseng eye lotion and a preparation method thereof. The ginseng eye lotion is prepared from the following raw materials in parts by weight: ginsenoside Rg 11-5 parts, ginsenoside Rh 1-5 parts, ginsenoside R01-3 parts, cornflower 18-22 parts, cassia seed 8-12 parts, pearl powder 3-7 parts, trehalose 5-9 parts, glycerol 3-7 parts, sodium hyaluronate 1-5 parts, tea polyphenol 3-7 parts, vitamin B60.5-1.5 parts and vitamin B119-23 parts. The ginseng eye lotion is prepared by the processes of extraction, distillation, concentration, fine filtration and the like, has the functions of nourishing eye nerves, cleaning eyeballs and the periphery of eyes, diminishing inflammation, resisting bacteria and removing eye garbage, and has mild property and no irritation.
Description
Technical Field
The invention relates to an eye lotion, and in particular relates to a ginseng eye lotion and a preparation method thereof.
Background
Eyes are exposed in the air for a long time and are fragile departments of human bodies, and the eyes are inevitably attacked by dust, haze and cosmetics for a long time to cause rough and greasy skin, accelerate aging and cause various eye diseases. The eye lotion can relieve discomfort, dryness and the like of eyes to a certain extent, and has the effects of refreshing, relieving itching, promoting nutrition of eyes, keeping eyes moist and sanitary, avoiding conjunctival congestion and the like.
Disclosure of Invention
The invention aims to provide the ginseng eye lotion and the preparation method thereof, and the ginseng eye lotion has the effects of nourishing eye nerves, cleaning eyeballs and the peripheries of eyes, diminishing inflammation, resisting bacteria and removing eye garbage, and is mild in property and free of irritation.
In order to achieve the above purpose, the technical scheme of the invention is as follows:
the invention provides a ginseng eye lotion which is prepared from the following raw materials in parts by weight:
ginsenoside Rg 11-5 parts, ginsenoside Rh 1-5 parts, ginsenoside R01-3 parts, cornflower 18-22 parts, cassia seed 8-12 parts, pearl powder 3-7 parts, trehalose 5-9 parts, glycerol 3-7 parts, sodium hyaluronate 1-5 parts, tea polyphenol 3-7 parts, vitamin B60.5-1.5 parts and vitamin B119-23 parts.
In the technical scheme, the ginseng eye lotion is preferably prepared from the following raw materials in parts by weight:
ginsenoside Rg 13, ginsenoside Rh 3, ginsenoside R02, cornflower 20, cassia seed 10, pearl powder 5, trehalose 7, glycerol 5, sodium hyaluronate 3, tea polyphenol 5, vitamin B61 and vitamin B121.
In the technical scheme, the ginseng eye lotion is preferably prepared from the following raw materials in parts by weight:
ginsenoside Rg 11, ginsenoside Rh 1, ginsenoside R01, cornflower 18, cassia seed 8, pearl powder 3, trehalose 5, glycerol 3, sodium hyaluronate 1, tea polyphenol 3, vitamin B60.5 and vitamin B119.
In the technical scheme, the ginseng eye lotion is preferably prepared from the following raw materials in parts by weight:
ginsenoside Rg 15, ginsenoside Rh 5, ginsenoside R03, cornflower 22, cassia seed 12, pearl powder 7, trehalose 9, glycerol 7, sodium hyaluronate 5, tea polyphenol 7, vitamin B61.5 and vitamin B123.
The invention also provides a preparation method of the ginseng eye lotion, which comprises the following steps:
weighing the raw materials according to the parts by weight, and then preparing the raw materials by the following method:
weighing the raw materials according to the parts by weight, and then preparing the raw materials by the following method:
step 1, adding water into cornflower and cassia seed for distillation extraction, and collecting distillate for later use;
step 2, adding a small amount of sodium chloride solution into the ginsenoside Rg1, ginsenoside Rh and ginsenoside R0 to dissolve, and then adding the dissolved solution into the distillate obtained in the step 1;
step 3, pulverizing pearls to 300 meshes, and adding the crushed pearls into the distillate obtained in the step 2;
step 4, adding trehalose, glycerol, sodium hyaluronate, tea polyphenol, vitamin B6 and vitamin B12 into the distillate in the step 3;
step 5, heating the distillate obtained in the step 4, cooling to room temperature, and filtering;
and step 6, subpackaging and sterilizing at high temperature to obtain the finished product.
In the above technical scheme, the distillate of the step 4 is preferably heated to 100 ℃ in the step 5 and then lasts for 20 minutes.
In the above technical solution, the time for the high-temperature sterilization in step 6 is preferably 30 minutes.
The invention has the beneficial effects that:
the invention provides a ginseng eye lotion, which is an eye lotion taking ginseng as a main raw material, and is prepared from ginsenoside (including ginsenoside Rg1, ginsenoside Rh and ginsenoside R0), cornflower, cassia seed, pearl powder, trehalose, glycerol, sodium hyaluronate, tea polyphenol, vitamin B6 and vitamin B12 through the processes of extraction, distillation, concentration, fine filtration and the like.
The ginsenoside Rg1 used in the invention can quickly relieve fatigue, improve learning and memory, delay aging, and has the functions of exciting central nerves and inhibiting platelet aggregation. Ginsenoside Rh has effects of inhibiting central nerve, hypnotizing, relieving pain, tranquilizing mind, relieving fever, and promoting serum protein synthesis. Ginsenoside R0 has antiinflammatory, toxic materials clearing away, antithrombotic, acid-series platelet coagulation inhibiting, hepatitis resisting, and macrophage activating effects. Cornflower has the effects of resisting infection, sterilizing, removing blood stasis, resisting virus, tranquilizing, relieving fever, nourishing and the like. Cassia seed, bitter, sweet, salty and slightly cold in nature, enters liver, kidney and large intestine meridians; moisten intestines to relieve constipation, reduce fat and improve eyesight. The hydrolyzed pearl powder contains 18 amino acids such as leucine, methionine, and alanine, and can be used for treating eye diseases, improving eyesight, and relieving eye swelling, eye oxygen, dry eye, and eye dryness. The trehalose can effectively protect the epidermal cell membrane structure, activate cells, condition the skin and make the skin healthy, natural and elastic. Glycerol and sodium hyaluronate have moisture keeping effect. Tea polyphenols have effects of scavenging free radicals, inhibiting lipoxygenase and lipid peroxidation in skin mitochondria, and thus have antiaging effect; the tea polyphenol has excellent radiation resistance, can absorb reflective substances and prevent the reflective substances from diffusing in a human body; the tea polyphenol can effectively eliminate eye injury caused by overuse of eyes and electronic screens, and has the functions of blue light resistance, radiation resistance, aging resistance and oxidation resistance; meanwhile, the tea polyphenol has the efficacy of killing various pathogens, germs and viruses, and can eliminate pathogens such as bacteria entering eyeballs. Vitamin B6 has effects in nourishing nerves and enhancing eye motility. Vitamin B12 is generally called a hematopoietic vitamin, and has an excellent effect of skin regeneration. The eye discomfort symptom can be relieved by the synergistic effect of the raw materials.
Detailed Description
The raw materials used in the following examples can be purchased directly, and the purity of the extracts of ginsenoside Rg1, ginsenoside Rh and ginsenoside R0 in the raw materials is more than 80%.
Example 1
The ginseng eye lotion is prepared from the following raw materials in parts by weight:
ginsenoside Rg 13, ginsenoside Rh 3, ginsenoside R02, cornflower 20, cassia seed 10, pearl powder 5, trehalose 7, glycerol 5, sodium hyaluronate 3, tea polyphenol 5, vitamin B61 and vitamin B121.
The ginseng eye lotion is prepared by the following preparation method:
weighing the raw materials according to the parts by weight, and then preparing the raw materials by the following method:
step 1, adding water into cornflower and cassia seed for distillation extraction, and collecting distillate for later use;
step 2, adding a small amount of sodium chloride solution into the ginsenoside Rg1, ginsenoside Rh and ginsenoside R0 to dissolve, and then adding the dissolved solution into the distillate obtained in the step 1;
step 3, pulverizing pearls to 300 meshes, and adding the crushed pearls into the distillate obtained in the step 2;
step 4, adding trehalose, glycerol, sodium hyaluronate, tea polyphenol, vitamin B6 and vitamin B12 into the distillate in the step 3;
step 5, heating the distillate obtained in the step 4 to 100 ℃, continuing for 20 minutes, cooling to room temperature, and filtering;
and 6, subpackaging into 15 mL/bottle, and sterilizing at high temperature for 30 minutes to obtain the finished product.
Example 2
The ginseng eye lotion is prepared from the following raw materials in parts by weight:
ginsenoside Rg 11, ginsenoside Rh 1, ginsenoside R01, cornflower 18, cassia seed 8, pearl powder 3, trehalose 5, glycerol 3, sodium hyaluronate 1, tea polyphenol 3, vitamin B60.5 and vitamin B119.
The ginseng eye lotion is prepared by the following preparation method:
weighing the raw materials according to the parts by weight, and then preparing the raw materials by the following method:
step 1, adding water into cornflower and cassia seed for distillation extraction, and collecting distillate for later use;
step 2, adding a small amount of sodium chloride solution into the ginsenoside Rg1, ginsenoside Rh and ginsenoside R0 to dissolve, and then adding the dissolved solution into the distillate obtained in the step 1;
step 3, pulverizing pearls to 300 meshes, and adding the crushed pearls into the distillate obtained in the step 2;
step 4, adding trehalose, glycerol, sodium hyaluronate, tea polyphenol, vitamin B6 and vitamin B12 into the distillate in the step 3;
step 5, heating the distillate obtained in the step 4 to 100 ℃, continuing for 20 minutes, cooling to room temperature, and filtering;
and 6, subpackaging into 15 mL/bottle, and sterilizing at high temperature for 30 minutes to obtain the finished product.
Example 3
The ginseng eye lotion is prepared from the following raw materials in parts by weight:
ginsenoside Rg 15, ginsenoside Rh 5, ginsenoside R03, cornflower 22, cassia seed 12, pearl powder 7, trehalose 9, glycerol 7, sodium hyaluronate 5, tea polyphenol 7, vitamin B61.5 and vitamin B123.
The ginseng eye lotion is prepared by the following preparation method:
weighing the raw materials according to the parts by weight, and then preparing the raw materials by the following method:
step 1, adding water into cornflower and cassia seed for distillation extraction, and collecting distillate for later use;
step 2, adding a small amount of sodium chloride solution into the ginsenoside Rg1, ginsenoside Rh and ginsenoside R0 to dissolve, and then adding the dissolved solution into the distillate obtained in the step 1;
step 3, pulverizing pearls to 300 meshes, and adding the crushed pearls into the distillate obtained in the step 2;
step 4, adding trehalose, glycerol, sodium hyaluronate, tea polyphenol, vitamin B6 and vitamin B12 into the distillate in the step 3;
step 5, heating the distillate obtained in the step 4 to 100 ℃, continuing for 20 minutes, cooling to room temperature, and filtering;
and 6, subpackaging into 15 mL/bottle, and sterilizing at high temperature for 30 minutes to obtain the finished product.
Comparative example
The eye lotion is prepared from the following raw materials in parts by weight:
20 parts of cornflower, 10 parts of cassia seed, 5 parts of pearl powder, 7 parts of trehalose, 5 parts of glycerol, 3 parts of sodium hyaluronate, 5 parts of tea polyphenol, 61 parts of vitamin B and 121 parts of vitamin B.
The eye lotion is prepared by the following preparation method:
weighing the raw materials according to the parts by weight, and then preparing the raw materials by the following method:
step 1, adding water into cornflower and cassia seed for distillation extraction, and collecting distillate for later use;
step 2, crushing pearl powder to 300 meshes, and adding the crushed pearl powder into the distillate obtained in the step 2;
step 3, adding trehalose, glycerol, sodium hyaluronate, tea polyphenol, vitamin B6 and vitamin B12 into the distillate in the step 3;
step 4, heating the distillate in the step 3 to 100 ℃, continuing for 20 minutes, cooling to room temperature, and filtering;
and 5, subpackaging into 15 mL/bottle, and sterilizing at high temperature for 30 minutes to obtain the finished product.
The eye lotion prepared in example 1 of the present invention was tested by Shanghai test article detection technology, Inc., and the test results are shown in Table 1 below:
TABLE 1
From the above detection results, it can be seen that: the eye lotion is safe and nontoxic.
The technical effects of the present invention will be further described by experiments.
Test subjects and grouping conditions:
the test population: volunteer subjects with ocular discomfort, symptoms including: asthenopia, dry eye, etc.; the product is suitable for patients with 20-40 years of age, no other diseases, short-term drug administration, and no allergy to the product.
40 subjects were randomly divided into 2 groups of 20 subjects each, labeled as control group and test group, according to eye condition and age.
The using method comprises the following steps: after the subjects washed their eyes with clear water, the control group washed their eyes and their peripheries with the eye lotion prepared in comparative example, and the test group washed their eyes and their peripheries with the eye lotion of example 1 of the present invention, and the control group and the test group were used for a period of time until the symptoms of eye fatigue and eye dryness were relieved, and the test days were recorded, and the results are shown in table 2 below.
TABLE 2
From the above table, it can be seen that the test group using the ginseng eyewash provided by the present invention can alleviate the eye fatigue and eyeball dryness in a short time, compared with the control group. The same effects as in example 1 were obtained by using the ginseng eyewash prepared in examples 2 and 3 to the above subjects, which are not listed here.
It should be understood that the above examples are only for clarity of illustration and are not intended to limit the embodiments. Other variations and modifications will be apparent to persons skilled in the art in light of the above description. And are neither required nor exhaustive of all embodiments. And obvious variations or modifications therefrom are within the scope of the invention.
Claims (7)
1. The ginseng eye lotion is characterized by being prepared from the following raw materials in parts by weight:
ginsenoside Rg 11-5 parts, ginsenoside Rh 1-5 parts, ginsenoside R01-3 parts, cornflower 18-22 parts, cassia seed 8-12 parts, pearl powder 3-7 parts, trehalose 5-9 parts, glycerol 3-7 parts, sodium hyaluronate 1-5 parts, tea polyphenol 3-7 parts, vitamin B60.5-1.5 parts and vitamin B119-23 parts.
2. The ginseng eyewash according to claim 1, characterized in that it is made from the following raw materials in parts by weight:
ginsenoside Rg 13, ginsenoside Rh 3, ginsenoside R02, cornflower 20, cassia seed 10, pearl powder 5, trehalose 7, glycerol 5, sodium hyaluronate 3, tea polyphenol 5, vitamin B61 and vitamin B121.
3. The ginseng eyewash according to claim 1, characterized in that it is made from the following raw materials in parts by weight:
ginsenoside Rg 11, ginsenoside Rh 1, ginsenoside R01, cornflower 18, cassia seed 8, pearl powder 3, trehalose 5, glycerol 3, sodium hyaluronate 1, tea polyphenol 3, vitamin B60.5 and vitamin B119.
4. The ginseng eyewash according to claim 1, characterized in that it is made from the following raw materials in parts by weight:
ginsenoside Rg 15, ginsenoside Rh 5, ginsenoside R03, cornflower 22, cassia seed 12, pearl powder 7, trehalose 9, glycerol 7, sodium hyaluronate 5, tea polyphenol 7, vitamin B61.5 and vitamin B123.
5. A method for preparing the ginseng eyewash according to any one of claims 1 to 4, comprising the steps of:
weighing the raw materials according to the parts by weight, and then preparing the raw materials by the following method:
step 1, adding water into cornflower and cassia seed for distillation extraction, and collecting distillate for later use;
step 2, adding a small amount of sodium chloride solution into the ginsenoside Rg1, ginsenoside Rh and ginsenoside R0 to dissolve, and then adding the dissolved solution into the distillate obtained in the step 1;
step 3, pulverizing pearls to 300 meshes, and adding the crushed pearls into the distillate obtained in the step 2;
step 4, adding trehalose, glycerol, sodium hyaluronate, tea polyphenol, vitamin B6 and vitamin B12 into the distillate in the step 3;
step 5, heating the distillate obtained in the step 4, cooling to room temperature, and filtering;
and step 6, subpackaging and sterilizing at high temperature to obtain the finished product.
6. The method for preparing ginseng eyewash according to claim 5, wherein the distillate of step 4 is heated to 100 ℃ for 20 minutes in step 5.
7. The method for preparing ginseng eyewash according to claim 5, wherein the time of high-temperature sterilization in step 6 is 30 minutes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911041542.2A CN110787211A (en) | 2019-10-30 | 2019-10-30 | Ginseng eye lotion and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911041542.2A CN110787211A (en) | 2019-10-30 | 2019-10-30 | Ginseng eye lotion and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110787211A true CN110787211A (en) | 2020-02-14 |
Family
ID=69442127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911041542.2A Pending CN110787211A (en) | 2019-10-30 | 2019-10-30 | Ginseng eye lotion and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110787211A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112870248A (en) * | 2021-02-20 | 2021-06-01 | 东莞市金基环保科技有限公司 | Plant negative ion eye protection liquid used in nano sprayer and preparation method thereof |
| CN113384614A (en) * | 2021-07-25 | 2021-09-14 | 北京阅亮科技有限公司 | Preparation method of eye care solution |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1080181A (en) * | 1993-03-22 | 1994-01-05 | 河南石油勘探局职工医院 | Skin-cleaning and sore-removing liquid |
| CN106581300A (en) * | 2015-10-20 | 2017-04-26 | 青岛益邦瑞达生物科技有限公司 | Eye drop |
| CN109010375A (en) * | 2018-09-11 | 2018-12-18 | 厦门阿欧客健康科技有限公司 | A kind of collyrium |
| CN110170000A (en) * | 2019-06-12 | 2019-08-27 | 丁贵华 | A kind of Chinese medicine composition and preparation method thereof for helping to improve eyesight |
-
2019
- 2019-10-30 CN CN201911041542.2A patent/CN110787211A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1080181A (en) * | 1993-03-22 | 1994-01-05 | 河南石油勘探局职工医院 | Skin-cleaning and sore-removing liquid |
| CN106581300A (en) * | 2015-10-20 | 2017-04-26 | 青岛益邦瑞达生物科技有限公司 | Eye drop |
| CN109010375A (en) * | 2018-09-11 | 2018-12-18 | 厦门阿欧客健康科技有限公司 | A kind of collyrium |
| CN110170000A (en) * | 2019-06-12 | 2019-08-27 | 丁贵华 | A kind of Chinese medicine composition and preparation method thereof for helping to improve eyesight |
Non-Patent Citations (1)
| Title |
|---|
| 大茉莉家游站: "比眼药水更安全的润眼神器！90秒雾化滋养，眼睛亮了也不干也不累了！", 《百度》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112870248A (en) * | 2021-02-20 | 2021-06-01 | 东莞市金基环保科技有限公司 | Plant negative ion eye protection liquid used in nano sprayer and preparation method thereof |
| CN113384614A (en) * | 2021-07-25 | 2021-09-14 | 北京阅亮科技有限公司 | Preparation method of eye care solution |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109091675B (en) | Compound low-concentration atropine medicine eye drops and preparation method thereof | |
| CN107875264A (en) | A kind of privates nursing bacteriostatic gel and preparation method thereof | |
| CN107397029A (en) | A kind of blueberry lutein ester pressed candy | |
| CN110787211A (en) | Ginseng eye lotion and preparation method thereof | |
| CN103316032B (en) | Compositions containing hydroxytyrosol and application thereof | |
| US20160051595A1 (en) | External-use medicament for cleaning and care of the ovaries, vagina and vulva | |
| CN105106318B (en) | A kind of Chinese medicine composition and preparation method thereof for treating xerophthalmia | |
| CN103749820B (en) | A kind of stir-fry seed of feather cockscomb tea clear liver and improved vision and preparation method thereof | |
| CN109745404A (en) | A kind of anti-visual fatigue and the Essence for nursing periocualr skin | |
| CN104524174A (en) | Traditional Chinese medicine composition for treating rheumatic arthralgia and preparation method thereof | |
| CN104524464A (en) | Traditional Chinese medicine preparation for treating hyperactivity and preparation method of traditional Chinese medicine preparation | |
| CN103860736B (en) | One treats cataractous Chinese medicine preparation and preparation method | |
| CN107898806A (en) | A kind of composition and its application with strong anti-inflammatory activity | |
| CN211095171U (en) | Eye-shade with effect of improving eyesight for myopia and presbyopia | |
| CN106620278A (en) | Bacteriostatic traditional Chinese medicinal eye drops as well as preparation method and application thereof | |
| CN105943718B (en) | Agilawood compound traditional Chinese medicine composition as well as preparation method and application thereof | |
| CN107519309B (en) | Ophthalmic combination suit | |
| CN112336838A (en) | Traditional Chinese medicine formula eye drop for treating xerophthalmia and preparation method thereof | |
| CN108785365A (en) | A kind of eyedrops for treating myopia | |
| CN114796322B (en) | Traditional Chinese medicine preparation for treating swelling and pain caused by injuries from falls and preparation method thereof | |
| CN106138913A (en) | A kind of pharmaceutical composition treating cerebral thrombosis and preparation method thereof | |
| CN106110009A (en) | One treats cataractous Chinese medicine preparation and preparation method | |
| CN111358867A (en) | Eye drop for treating cataract | |
| CN105641255A (en) | Eye drops capable of diminishing inflammation, inducing resuscitation and improving eyesight and preparation method of eye drops | |
| CN104547342A (en) | Rapid hemostasis external application powder for clinical nursing and preparation method of rapid hemostasis external application powder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 134000 Tonghua city of Jilin Province Dongchang District left Road No. 1687 Applicant after: Lishen Pharmaceutical (Jilin) Co.,Ltd. Address before: 134000 Tonghua city of Jilin Province Dongchang District left Road No. 1687 Applicant before: TONGHUA LISHEN HEALTH PRODUCTS Co.,Ltd. |
|
| CB02 | Change of applicant information | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200214 |
|
| RJ01 | Rejection of invention patent application after publication |